Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.

"Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025" presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.

Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.

Further, prudent analysis has been done on the competitor's part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech, VaxInnate and BioDiem are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.


The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.

The major and emerging companies dominating this market for its vaccines, services and continuous product developments are:

• Sanofi Pasteur
• GlaxoSmithKline (GSK)
• Seqirus (CSL Limited)
• AstraZeneca
• Mylan
• Sinovac Biotech Ltd.
• Gamma Vaccines Pty Ltd.
• Hualan Biological Engineering Inc.
• Shanghai Institute of Biological Products Co., Ltd.
• Novavax
• Daiichi-Sankyo
• Mitsubishi Tanabe Pharma
• BiondVax Pharmaceuticals Ltd
• Altimmune
• FluGen
• Moderna
• Vaccitech
• VaxInnate
• BioDiem

Twenty-One Major Markets (21MM) covered in the report are as follows:

• United States
• Canada
• Germany
• France
• Italy
• Spain
• United Kingdom
• Netherlands
• Sweden
• Denmark
• Poland
• Norway
• Finland
• Ireland
• Belgium
• Australia
• New Zealand
• Japan
• Brazil
• China
• India

The Latest Industry Data Included in this Report:

• Global Influenza Vaccines Market Size and Analysis (2013 - 2025)
• Global Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
• Global Influenza Vaccines Market Share Analysis and Forecast (2013 - 2025)
• Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 - 2025)
• Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 - 2025)
• Rapid Diagnostic Testing for the Management of Influenza
• Global Distribution Channel and Technique of Influenza Vaccination
• Promising Influenza Vaccines in Clinical Development
• Major Deals in the Global Influenza Vaccines Market
• Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development

The Report Answers the Following Questions about the Global Influenza Vaccines Market:

• How has the global influenza vaccines market performed so far and how will it perform in the coming years?
• What are the key markets in the global influenza vaccines industry?
• How many numbers of persons being vaccinated with influenza vaccines globally during 2013 - 2025?
• What are the key drivers and inhibitors in the current market?
• What are the various influenza vaccines available globally?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
1. Executive Summary

2. Global Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)

3. Global Influenza Vaccines Market Size and Analysis (2013 - 2025)

4. Global Influenza Vaccines Market Share Analysis and Forecast (2013 - 2025)
4.1 Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast
4.2 Global Influenza Vaccines Market Share and Forecast

5. Key Drivers and Inhibitors of the Global Influenza Vaccines Market
5.1 Market Drivers
5.2 Market Inhibitors

6. Global Influenza Vaccines Market in Top 21 Countries - Geographical Landscape (Volume and Value) (2013 - 2025)
6.1 United States
6.1.1 United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.1.2 United States Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.2 Canada
6.2.1 Canada Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.2.2 Canada Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.3 Germany
6.3.1 Germany Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.3.2 Germany Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.4 France
6.4.1 France Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.4.2 France Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.5 Italy
6.5.1 Italy Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.5.2 Italy Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.6 Spain
6.6.1 Spain Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.6.2 Spain Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.7 United Kingdom
6.7.1 United Kingdom Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.7.2 United Kingdom Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.8 Netherlands
6.8.1 Netherlands Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.8.2 Netherlands Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.9 Sweden
6.9.1 Sweden Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.9.2 Sweden Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.10 Denmark
6.10.1 Denmark Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.10.2 Denmark Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.11 Poland
6.11.1 Poland Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.11.2 Poland Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.12 Norway
6.12.1 Norway Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.12.2 Norway Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.13 Finland
6.13.1 Finland Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.13.2 Finland Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.14 Ireland
6.14.1 Ireland Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.14.2 Ireland Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.15 Belgium
6.15.1 Belgium Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.15.2 Belgium Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.16 Australia
6.16.1 Australia Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.16.2 Australia Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.17 New Zealand
6.17.1 New Zealand Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.17.2 New Zealand Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.18 Japan
6.18.1 Japan Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.18.2 Japan Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.19 Brazil
6.19.1 Brazil Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.19.2 Brazil Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.20 China
6.20.1 China Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.20.2 China Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.21 India
6.21.1 India Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.21.2 India Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.22 Other Countries
6.22.1 Other Countries Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.22.2 Other Countries Influenza Vaccines Market Size & Analysis (2013 - 2025)

7. Rapid Diagnostic Testing for the Management of Influenza

8. Global Distribution Channel and Technique of Influenza Vaccination

9. Promising Influenza Vaccines in Clinical Development

10. Major Deals in the Global Influenza Vaccines Market
10.1 Merger& Acquisitions
10.2 Collaboration Deal
10.3 Licensing Agreement
10.4 Exclusive Agreement
10.5 Distribution Agreement

11. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
11.1 Year 2018
11.2 Year 2017

12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Influenza Vaccines Portfolio
12.1.3 Influenza Vaccine Value Sales Analysis
12.1.4 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Influenza Vaccines Portfolio
12.2.3 Influenza Vaccine Sales Value Analysis
12.2.4 Recent Development
12.3 Seqirus (CSL Limited)
12.3.1 Business Overview
12.3.2 Influenza Vaccines Portfolios
12.3.3 Recent Development
12.4 AstraZeneca
12.4.1 Business Overview
12.4.2 Influenza Vaccines Portfolio
12.4.3 Influenza Vaccine Sales Value Analysis
12.4.4 Recent Development
12.5 Sinovac Biotech Ltd.
12.5.1 Business Overview
12.5.2 Influenza Vaccines Portfolio
12.5.3 Influenza Vaccine Sales Value Analysis
12.5.4 Recent Development
12.6 Gamma Vaccines Pty Ltd
12.6.1 Business Overview
12.6.2 Influenza Vaccines Portfolio
12.6.3 Recent Development
12.7 Hualan Biological Engineering Inc
12.7.1 Business Overview
12.7.2 Influenza Vaccines Portfolio
12.7.3 Recent Development
12.8 Shanghai Institute of Biological Products Co., Ltd.
12.8.1 Business Overview
12.8.2 Influenza Vaccine Portfolio
12.9 Mylan
12.9.1 Business Overview
12.9.2 Influenza Vaccine Portfolio
12.10 BioDiem
12.10.1 Business Overview
12.10.2 Influenza Vaccine Portfolio
12.10.3 Recent Development

Global Pharma & Vaccines Logistics Market Research Report 2019-2023

Published Date : Jun 2019

Logistics is a key component in the biopharmaceutical supply chain. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Pharma & Vaccines Logistics Report by Material, Application, and Geography - Global Forecast to 2023 i...

Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

Published Date : Jun 2019

The global vaccines market size is expected to exceed US$ 48 Billion by the year-end of 2025. "Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025" presents an in-depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive...

Global Anthrax Vaccines Market Data Survey Report 2013-2025

Published Date : May 2019

Summary Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides. The global Anthrax Vaccines market will reach xxx Million USD in 2019 with CA...

Global Flu Vaccine (Influenza Vaccine) Market Data Survey Report 2013-2025

Published Date : May 2019

Summary The global Flu Vaccine (Influenza Vaccine) market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile...

Global Foot and Mouth Disease Vaccines Market Data Survey Report 2013-2025

Published Date : May 2019

Summary Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats....

Global Porcine Epidemic Diarrhea Vaccines Market Data Survey Report 2013-2025

Published Date : May 2019

Summary The global Porcine Epidemic Diarrhea Vaccines market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers prof...

Global Conjugate Vaccines Market (2017 - 2022)

Published Date : Dec 2019

The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of certain life-threatening diseases, growing initiatives for production of low-cost vaccines, and widespread routine vaccination programmes in emerging economies...

Global mRNA Vaccines & Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Mar 2019

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh...

Global Foot and Mouth Disease Vaccines Market Professional Survey Report 2019

Published Date : Mar 2019

This report studies Foot and Mouth Disease Vaccines in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to2018, and forecast to2024. This report focuses on top...

Global Influenza Drugs Sales Market Report 2019

Published Date : Mar 2019

In this report, the global Influenza Drugs market is valued at USD XX million in2018 and is expected to reach USD XX million by the end of2024, growing at a CAGR of XX% between2018 and2024. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Mi...

 

Select License :

  • Single User : $2190
  • Multiple User : $2990
  • Corporate User : $2990

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.